MENU
+Compare
ATHA
Stock ticker: NASDAQ
AS OF
Sep 3 closing price
Price
$0.39
Change
-$0.00 (-0.00%)
Capitalization
15.54M

ATHA Athira Pharma Forecast, Technical & Fundamental Analysis

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATHA with price predictions
Sep 02, 2025

ATHA in +3.96% Uptrend, growing for three consecutive days on August 25, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ATHA advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 170 cases where ATHA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ATHA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATHA as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATHA turned negative on August 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATHA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.486) is normal, around the industry mean (19.852). P/E Ratio (0.000) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.082).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ATHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATHA is expected to report earnings to fall 24.06% to -13 cents per share on November 06

Athira Pharma ATHA Stock Earnings Reports
Q3'25
Est.
$-0.14
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 97.02K shares outstanding, the current market capitalization sits at 15.54M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR27.802.12
+8.26%
Arrowhead Pharmaceuticals
VALN8.770.15
+1.68%
Valneva SE
IBKR63.950.05
+0.08%
Interactive Brokers Group Inc
HNVR22.25-0.05
-0.22%
Hanover Bancorp
AMZE2.51-0.02
-0.79%
Amaze Holdings Inc

ATHA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with CSCI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then CSCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+1.81%
CSCI - ATHA
42%
Loosely correlated
-11.69%
DYN - ATHA
37%
Loosely correlated
-0.15%
OGEN - ATHA
35%
Loosely correlated
+1.90%
MNKD - ATHA
33%
Poorly correlated
-4.01%
PBM - ATHA
32%
Poorly correlated
-6.03%
More